Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/20 → 6/1/22 |
Funding
- Adamis Pharmaceuticals Corporation: $89,654.33
Evaluate the Efficacy of Tempol, an Anti-inflammatory Drug, against Pulmonary Inflammation Caused by SARS-CoV-2 Infection in Hamsters
- Tseng, Chien-Te (PI)
Project: Other project